SGHT on Nasdaq

Sight Sciences, Inc.

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with PRO DEX INC, TELA Bio, Inc. or Avita Medical, or pick any stock.

  • TickerSGHT on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersMenlo Park, California1
  • Incorporated inDE2
  • Business address4040 Campbell Ave,, Suite 100, Menlo Park, Ca 940252
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

86.2%Gross margin3
-48.0%Operating margin3
-49.7%Net margin3
-3.1%Revenue growth, 20253
-60.1%Return on equity3
0.63×Debt to equity3
-$29.9MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Surgical Glaucoma brought in 98% of the revenue Sight Sciences, Inc. broke down this way in fiscal 2025.

  1. Surgical Glaucoma$75.7M398%down 0% from 2024
  2. Dry Eye$1.6M32%down 59% from 2024
Business segments by year
Business segments20242025
Surgical Glaucoma$75.9M$75.7M
Dry Eye$4.0M$1.6M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue9¢$10.7M
  • Research and development12¢$14.6M
  • Selling, general and admin75¢$89.2M
  • Interest4¢$5.1M
  • Income tax0¢$10.0K

Out of $77.4M in revenue.3 The company lost money this year.

Financial statements

Revenue45673$77.4M in 2025+180% since 2020
0$25.0M$50.0M$75.0M$100.0M2020: $27.6M$27.6M20202021: $49.0M$49.0M2021+77%2022: $71.3M$71.3M2022+46%2023: $81.1M$81.1M2023+14%2024: $79.9M$79.9M2024−1%2025: $77.4M$77.4M2025−3%
Gross profit45673$66.7M in 2025+262% since 2020
0$20.0M$40.0M$60.0M$80.0M2020: $18.4M$18.4M20202021: $40.3M$40.3M2021+119%2022: $59.0M$59.0M2022+46%2023: $69.2M$69.2M2023+17%2024: $68.3M$68.3M2024−1%2025: $66.7M$66.7M2025−2%
Operating income45673-$37.1M in 2025+15% since 2020
-$100.0M-$75.0M-$50.0M-$25.0M02020: -$32.2M-$32.2M20202021: -$51.5M-$51.5M2021+60%2022: -$84.0M-$84.0M2022+63%2023: -$57.3M-$57.3M2023−32%2024: -$50.5M-$50.5M2024−12%2025: -$37.1M-$37.1M2025−27%
Net income45673-$38.4M in 2025+11% since 2020
-$100.0M-$75.0M-$50.0M-$25.0M02020: -$34.7M-$34.7M20202021: -$63.0M-$63.0M2021+81%2022: -$86.2M-$86.2M2022+37%2023: -$55.5M-$55.5M2023−36%2024: -$51.5M-$51.5M2024−7%2025: -$38.4M-$38.4M2025−25%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Revenue$77.4M$79.9M
Cost of goods sold$10.7M$11.6M
Gross profit$66.7M$68.3M
Research and development$14.6M$18.0M
Selling, general and administrative$89.2M$100.8M
Total operating expenses$103.8M$118.8M
Loss from operations-$37.1M-$50.5M
Investment income$4.0M$5.9M
Interest expense-$5.1M-$4.7M
Loss on debt extinguishment$0-$2.0M
Other expense, net-$148.0K-$32.0K
Loss before income taxes-$38.4M-$51.3M
Provision for income taxes$10.0K$236.0K
Net loss and comprehensive loss-$38.4M-$51.5M
Net loss per share attributable to common stockholders-basic-$0.74-$1.03
Net loss per share attributable to common stockholders-diluted-$0.74-$1.03
Weighted-average shares of common stock outstanding-basic52.1M shares50.1M shares
Weighted-average shares of common stock outstanding-diluted52.1M shares50.1M shares

Compare Sight Sciences, Inc. with another company

Leadership

Who has led Sight Sciences, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Paul Badawi2021–now

President

  1. Paul Badawi2021–now

Chief financial officer

  1. Jesse Selnick2021–2023
  2. Alison Bauerlein2024–2025
  3. James Rodberg2025–now

Chief operating officer

  1. Alison Bauerlein2025–now
2025
Board members and other officers (20)

Timeline

  1. Jul 14, 2021New chief executive Paul Badawi becomes CEO10

Filings

452 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 63 major events, 204 insider forms, 23 large holders, 142 other. The latest 20:

  1. Oct 5, 20264 EDGAR
  2. Oct 5, 20264 EDGAR
  3. Oct 5, 20264 EDGAR
  4. Oct 5, 20264 EDGAR
  5. Oct 5, 20264 EDGAR
  6. Oct 2, 2026144 EDGAR
  7. Oct 2, 2026144 EDGAR
  8. Oct 2, 2026144 EDGAR
  9. Oct 1, 2026144 EDGAR
  10. Oct 1, 2026144 EDGAR
  11. Oct 1, 2026144 EDGAR
  12. Sep 30, 2026144 EDGAR
  13. Sep 4, 2026144 EDGAR
  14. Sep 1, 2026144 EDGAR
  15. Aug 18, 20264 EDGAR
  16. Aug 18, 20263 EDGAR
  17. Aug 17, 2026144 EDGAR
  18. Aug 14, 2026144 EDGAR
  19. Aug 13, 2026144 EDGAR
  20. Aug 12, 2026144 EDGAR

The 452 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

122 open-market trades by officers, directors and large owners since October 2021: 38 buys and 84 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 6, 2026HAYDEN JEREMY B.Chief Legal OfficerSale12,733$5.51$70.2KForm 4
Jul 6, 2026Badawi DavidChief Technology OfficerSale7,418$5.51$40.9KForm 4
Jul 2, 2026Rodberg JamesChief Financial OfficerSale6,902$5.36$37.0KForm 4
Jul 2, 2026Bauerlein AlisonChief Operating OfficerSale24,184$5.36$129.6KForm 4
Jul 1, 2026Taylor BrentonEVP, Operations & R&DSale2,829$5.42$15.3KForm 4
Jul 1, 2026Badawi PaulPresident and CEOSale28,684$5.42$155.5KForm 4
Jun 10, 2026Encrantz StaffanDirectorBuy14,100$4.88$68.8KForm 4
May 18, 2026Bauerlein AlisonChief Operating OfficerSale12,728$5.12$65.2KForm 4
Apr 6, 2026Rodberg JamesChief Financial OfficerSale7,231$3.55$25.7KForm 4
Apr 6, 2026HAYDEN JEREMY B.Chief Legal OfficerSale13,761$3.55$48.9KForm 4
Apr 2, 2026Bauerlein AlisonChief Operating OfficerSale25,874$3.48$90.0KForm 4
Apr 2, 2026Badawi DavidChief Technology OfficerSale8,168$3.48$28.4KForm 4
Apr 1, 2026Taylor BrentonEVP, Operations & R&DSale2,869$3.70$10.6KForm 4
Apr 1, 2026Badawi PaulPresident and CEOSale29,244$3.70$108.2KForm 4
Jan 16, 2026Badawi DavidChief Technology OfficerSale4,836$6.62$32.0KForm 4
Jan 16, 2026Rodberg JamesChief Financial OfficerSale2,616$6.62$17.3KForm 4
Jan 16, 2026Badawi PaulPresident and CEOSale22,362$6.62$148.0KForm 4
Jan 16, 2026HAYDEN JEREMY B.Chief Legal OfficerSale6,308$6.62$41.8KForm 4
Jan 6, 2026Badawi PaulPresident and CEOSale11,870$7.48$88.8KForm 4
Jan 6, 2026HAYDEN JEREMY B.Chief Legal OfficerSale1,785$7.48$13.4KForm 4

All 122 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Long Focus Capital Management, LLC3,844,100$20.8M0.8%+250,000
BlackRock, Inc.3,083,108$16.7M0.0%+251,176
Americana Partners, LLC1,679,069$9.1M0.2%+52
Pathstone Holdings, LLC1,678,980$9.1M0.0%−718,352
Vanguard Capital Management LLC1,573,815$8.5M0.0%+121,125
Geode Capital Management, LLC958,565$5.2M0.0%+43,121
State Street Corp835,452$4.5M0.0%+424
B Group, Inc.970,000$3.7M2.1%No change
Aqr Capital Management LLC397,558$2.2M0.0%+259,041
Dimensional Fund Advisors LP383,512$2.1M0.0%+41,831
Qube Research & Technologies Ltd362,703$2.0M0.0%−134,805
Northern Trust Corp343,582$1.9M0.0%+11,273
Jacobs Levy Equity Management, Inc338,441$1.8M0.0%+10,529
D. E. Shaw & Co., Inc.279,949$1.5M0.0%−31,425
Charles Schwab Investment Management Inc275,553$1.5M0.0%−3,036
Vanguard Portfolio Management LLC272,485$1.5M0.0%+23,402
Panagora Asset Management Inc262,528$1.4M0.0%+68,361
Vanguard Fiduciary Trust Co256,078$1.4M0.0%+15,153
Squarepoint Ops LLC218,108$1.2M0.0%−113,646
Citadel Advisors LLC216,307$1.2M0.0%+81,004
Renaissance Technologies LLC212,658$1.2M0.0%−80,700
Russell Investments Group, Ltd.210,161$1.1M0.0%+4,162
Goldman Sachs Group Inc200,127$1.1M0.0%+73,737
Morgan Stanley155,222$841.3K0.0%−29,923
Palumbo Wealth Management LLC128,536$696.7K0.1%+78,606

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43